# A Study to Assess NEU-627 in Healthy Participants

> **NCT06900751** · PHASE1 · COMPLETED · sponsor: **Neuron23 Inc.** · enrollment: 74 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** NEU-627
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06900751
- **Lead sponsor:** Neuron23 Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-06-02
- **Primary completion:** 2025-10-28
- **Final completion:** 2025-10-28
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06900751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06900751, "A Study to Assess NEU-627 in Healthy Participants". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT06900751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*